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Infections of Asian elephants (Elephas maximus) with elephant endotheliotropic herpesvirus (EEHV) can
cause a rapid, highly lethal, hemorrhagic disease, which primarily affects juvenile animals up to the age of
four years. So far, the majority of deaths have been attributed to infections with genotype EEHV1 or, more
rarely, EEHV3 and EEHV4. Here, we report the pathological characteristics of the first fatality linked to
EEHV5 infection, and describe the complete viral DNA sequence. Gross post-mortem and histological
findings were indistinguishable from lethal cases previously attributed to other EEHV genotypes, and the
presence of characteristic herpesviral inclusions in capillary endothelial cells at several sites was consistent
with the diagnosis of acute EEHV infection. Molecular analysis confirmed the presence of EEHV5DNA and
was followed by sequencing of the viral genome directly from post-mortem material. The genome is
180,800 bp in size and contains 120 predicted protein-coding genes, five of which are fragmented and
presumably nonfunctional. The seven families of paralogous genes recognized in EEHV1 are also
represented in EEHV5. The overall degree of divergence (37%) between the EEHV5 and EEHV1 genomes,
and phylogenetic analysis of eight conserved genes, support the proposed classification of EEHV5 into a new
species (Elephantid herpesvirus 5).
S
ince the first reported death attributed to a herpesvirus in an Asian elephant (Elephas maximus) in 19881,
elephant endotheliotropic herpesvirus (EEHV) infection has emerged as a serious threat to captive and wild
Asian elephant populations. To date, seven distinct genotypes, named EEHV1 to EEHV7, have been
identified in Asian elephants and African elephants (Loxodonta africana). The spectrum of associated disease
ranges from subclinical infection to rapidly fatal hemorrhagic disease2. The genotype most often involved in
fatalities is EEHV1, and the complete genome sequences of the two subgenotypes (EEHV1A and EEHV1B) were
resolved recently3,4. Two further genotypes, EEHV3 and EEHV4, are known to cause sporadic fatalities in young
Asian elephants, and EEHV2 has been attributed to a similar disease in African elephants5–8. The tropism of
EEHVs for endothelium results in widespread capillary damage and subsequent lethal pericardial, thoracic and
abdominal effusions and variably extensive hemorrhages in a variety of tissues7–9.
EEHV5 was first detected in 2007 in whole blood samples from a clinically healthy, 59 year-old, wild-born
Asian elephant7. This genotype has since been associated with a small number of subclinical and clinical infections
in captive Asian elephants10. Clinical findings in an EEHV5-positive herd included bilaterally swollen temporal
glands, oral mucosal hyperaemia, vesicles on the tongue, and generalized lethargy in an otherwise healthy adult
and a one year-old calf. DNA sequence analysis revealed the presence of EEHV5 subgenotypes (EEHV5A and
EEHV5B) within the herd, but no fatalities were recorded10.
Initial DNA sequence characterization of EEHV1A and EEHV1B5,11,12 was instrumental in classifying the
viruses into the species Elephantid herpesvirus 1 in the genus Proboscivirus, subfamily Betaherpesvirinae, family
Herpesviridae, order Herpesvirales13. Derivation of the complete genome sequences of two EEHV1A strains
(EEHV1A/Kimba and EEHV1A/Raman; GenBank accession numbers KC618527 and KC462165, respectively)
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and one EEHV1B strain (EEHV1B/Emelia; KC462164) recently pro-
vided substantial insights into the genetic compositions of these
viruses, which are characterized by numerous genes lacking counter-
parts in other herpesviruses3,4. In this report, we describe detailed
pathological findings and a complete viral genome sequence from the
first case of EEHV5-associated fatality in an Asian elephant.
Methods
Case history.The affected animal was a juvenile Asian elephant, Vijay (=; barn name;
official name Ganesh), which was born at Twycross Zoo, UK, within a herd of four
adult, female Asian elephants on 6 August 2009 (http://www.elephant.se/database2.
php?elephant_id54826). This animal had a history of retarded growth and ill-health,
and developed an oral lesion during December 2010 and a mucocutaneous perianal
lesion duringMarch 2011, both of which resolved spontaneously over a period of 2–3
weeks. In April 2011, lethargy followed by rapidly progressive hemorrhages of
mucosal membranes, edema, and lingual cyanosis led to the presumptive clinical
diagnosis of EEHV infection. Treatment followed protocols for extensive antiviral
and supportive therapy, including drainage of the pericardial effusion under
ultrasonographic guidance. Despite all efforts over a period of 6 days, the calf’s health
deteriorated, and the decision was made to euthanize the animal. All treatments and
clinical decision making in this case were conducted in accordance with the
Veterinary Surgeons Act under the direct supervision of a RCVS Specialist andwithin
the ethical policies of the zoo.
Pathology. A comprehensive post-mortem procedure following elephant necropsy
protocols14 was carried out within 24 hours. For histological examination, tongue,
heart, lung, spleen, liver, kidneys, stomach, and all segments of intestine, urinary
bladder, skeletal muscle, thyroid, adrenal and salivary glands, skin, oral mucosa and a
section of trunk, pharyngeal lymphoid tissue, lymph nodes, trigeminal nerve, brain
(including the pituitary gland), medulla, and bone marrow were processed routinely,
and paraffin-embedded sections were stained with hematoxylin and eosin.
Viral diagnosis.DNAwas extracted from heart, tongue, trunk mucosa, whole blood,
and serum samples by using a DNeasy blood and tissue kit (Qiagen, Crawley, UK). It
was tested for EEHV1A and EEHV1B by using a published PCR method15, and for
EEHV2 to EEHV6 by using previously unpublished PCR methods, with all assays
targeting regions of the DNA polymerase gene (U38). Semi-nested PCRs for EEHV2/
EEHV5/EEHV6 were performed by using forward primer 59-GTT ACS RYB GTY
ACSACTAACAC-39with reverse primers 59-GCTATMGSYARACACGGRAAC
AT-39 in the first round and 59-ACR GCR TTR CAY GTD AGT TTC AG-39 in the
second round. Semi-nested PCRs for EEHV3/EEHV4 were carried out by using
forward primer 59-CAT CCAGGCCTACAACCTCTG-39with reverse primers 59-
CAG TCG TTG AAG GTG TCG CAG-39 and 59-AGA CGG CGT TGC AGG TGA
GCT-39 in the first and second rounds, respectively. The predicted PCR product sizes
for EEHV2/EEHV5/EEHV6 and EEHV3/EEHV4 were 204 and 281 bp, respectively.
The tissues were also tested by using nested pan-EEHV and specific EEHV5 PCRs7,
performing the first round PCRs only.
The PCRs were performed by using a fast cycling PCR kit (Qiagen), the reactions
consisting of 10 ml 23 fast cycling PCRmaster mix, 1 ml each of forward and reverse
primers at 20 pmol/ml, 2 ml template DNA, andwater to a total volume of 20 ml. PCRs
were initiated at 95uC for 5 min, followed by 35 cycles of 95uC for 15 s, 55uC for 30 s,
and 72uC for 1 min. The products were detected by agarose gel electrophoresis,
purified by using a MinElute PCR purification kit (Qiagen), and sequenced by using
Sanger technology.
DNA sequencing. An aliquot of DNA (240 ng) from heart tissue was sheared
acoustically to an average size of 525 bp in a volume of 50 ml, using a Covaris S220
sonicator (Covaris Inc., Woburn, MA, USA). Fragment size was measured on an
Agilent 2200 TapeStation (Agilent, Santa Clara, CA, USA). A KAPA library
preparation kit (KAPA Biosystems, Wilmington, MA, USA) was used to prepare the
sheared DNA fragments for Illumina sequencing, with the followingmodifications of
the standard protocol. Sheared DNA was end-repaired directly (i.e., without
isolation), and end-repaired DNA was purified by using 0.8 volumes of AMPureXP
beads (Beckman Coulter, Indianapolis, IN, USA) in order to remove fragments
smaller than the anticipated read length (250 bp), and eluted in 30 ml TE (10 mM
Tris-HCl, pH 8.5), retaining the beads in the tube during all subsequent steps in order
to minimize sample loss16. A 2051 molar ratio of NEBnext Illumina adaptor (New
England Biolabs, Ipswich, MA, USA) was ligated to the DNA fragments. In order to
reduce PCR amplification bias and improve fidelity, the adaptor-ligated DNA was
amplified by three cycles on an ABI 7500 real-time PCR cycler (Life Technologies,
Grand Island, NY, USA) using a KAPA real-time library amplification kit.
A MiSeq DNA sequencer running v2 chemistry (Illumina, San Diego, CA, USA)
was used to generate 15,054,115 paired-end, 250 nucleotide (nt) reads from the Vijay/
EEHV5 library. The data were processed for adapter removal, quality-filtered,
trimmed, and subjected to read pair validation by using Trim Galore v. 0.2.2 (http://
www.bioinformatics.babraham.ac.uk/projects/trim_galore), yielding 15,002,189
paired-end reads. In order to identify host data, BWA v. 0.6.2-r12617 was used in
gapped, paired-end mode to map reads to the African elephant genome (Ensembl
Loxafr3.0 v. 69.3), since the Asian elephant genome was not available. Unmapped
read pairs were extracted by using Samtools v. 0.1.1818, and contigs were assembled de
novo by using ABySS19. Scaffold_builder20 was used to produce a draft sequence by
ordering the contigs against the EEHV1A/Raman genome sequence. Additional
contigs were incorporated, and gaps were closed by using Megamerger21, GapFiller v.
1–1122, and custom Perl scripts. The integrity of the resulting single, circular contig
was verified by aligning against the original dataset using BWA and visualizing using
Tablet v. 1.13.08.0523.
Identification of genome termini. The termini of the EEHV5 genome were
identified essentially as described for EEHV1A/Raman and EEHV1B/Emelia4, using
components described in the KAPA library preparation kit (KAPA Biosystems) and
Marathon cDNA amplification kit (Clontech Laboratories, Palo Alto, CA, USA)
according to themanufacturers’ instructions. Briefly, aliquots of DNA extracted from
heart tissue were either blunt-ended or left untreated. The former DNAwas ligated to
a partially double-stranded DNA adaptor that was blunt at the end designed to ligate
to the genome termini, and the latter DNA to a corresponding adaptor that contained
an additional unpaired, redundant 39-nucleotide (i.e., a mixture of G, A, T, and C).
First-round PCR was then carried out on the two ligation products by using an
EEHV5-specific primer mapping close to the anticipated left or right genome
terminus, plus an adaptor-specific primer (AP1). The locations of the EEHV5 termini
were predicted from sequence similarities to those of EEHV1A. The EEHV5-specific
primers were 59-TCC GGG AGG GTA TAC GTC ACG GTG-39 (left terminus) and
59-CAG AGA TGA TTG ACG TCT ACA CGG-39 (right terminus). Although PCR
products were not detectable as visible bands by agarose gel electrophoresis, the
regions containing DNA molecules of the anticipated sizes (approximately 200 and
180 bp, respectively) were purified. Nested PCR was carried out on each product by
using EEHV5-specific primers 59-TTA CTA TGA CGT CAT GAC CGG AAG-39
(left terminus) or 59-GCCCACCCGCCAGCGGTAATGACT-39 (right terminus),
plus a second adaptor-specific primer (AP2). The PCR products (approximately 160
and 110 bp, respectively) were detected by agarose gel electrophoresis, purified by
using a Geneclean turbo kit (MP Biomedicals, Solon, OH, USA), and cloned into
plasmids by using the pGEM-T vector system (Promega Corporation, Madison, WI,
USA) according to the manufacturer’s instructions. The inserts in 12 plasmids for
each of the four products were sequenced by using Sanger technology with universal
primers, and the termini were defined as being located at the positions in the circular
sequence represented by the majority of clones.
Sequence comparisons. Overall percentages of sequence identity between EEHV
genomes were assessed using Stretcher (http://emboss.bioinformatics.nl). Similarity
among imputed amino acid sequences was investigated by using Needle (http://
emboss.bioinformatics.nl). Phylogenetic trees were constructed by using Neighbor-
Joining and Poisson model implemented in the MEGA v. 5.03 software24 with
confidence values calculated from 2000 replicates, having obtained sequences from
NCBI RefSeq (http://www.ncbi.nlm.nih.gov/genomes/GenomesGroup.
cgi?taxid510292). Matrix sequence comparison plots were computed by using
Compare (window5 20, stringency5 16) and Dotplot in the GCG package (http://
www.accelrys.com).
Database accession. The genome sequence of EEHV5/Vijay was deposited in NCBI
GenBank under accession number KF921519.
Results
Pathological findings. On gross post-mortem examination, Vijay
presented in good body condition. No skin lesions were identified on
careful examination. The tongue was enlarged and cyanotic, with
multifocal (petechial to ecchymosal) mucosal and intraparen-
chymal hemorrhages. The head, in particular the eyelids, was
swollen, with moderate to marked subcutaneous edema accom-
panied by few disseminated subcutaneous petechial hemorrhages.
Petechial to ecchymotic hemorrhages were in addition detected
within the conjunctiva, brain (including meninges), esophagus,
trachea, stomach, intestine and mesentery, liver, urinary bladder,
and adrenal glands. Extensive atrial and ventricular hemorrhages
were observed within the heart, comprising severe, confluent,
irregular areas of subepicardial and subendocardial bleeding extend-
ing into themyocardium and papillarymusculatures25. Severe edema
and multifocal subserosal hemorrhages, typical of EEHV-induced
lesions, were observed in the dorsal mediastinum (Fig. 1a). Free
accumulations of approximately 500–700 ml of clear, watery fluid
were present within the abdominal cavity, accompanying marked
expansion of the intestinal wall, mesentery, and omentum by
edema. The kidneys were diffusely congested, with mottled light-
to dark-red cut surfaces and retained cortico-medullary distinc-
tion. The uniformly dark-red lungs exhibited multifocal subpleural
hemorrhages. Generalized diffuse reddening and mild enlargement
were noted in examined visceral and subcutaneous lymph nodes.
www.nature.com/scientificreports
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On histological examination, varying degrees of multifocal, acute
hemorrhage with underlying vascular changes, including edema of
the vascular wall, mild endothelial cell hypertrophy, and occasional
fibrinoid necrosis with thrombus formation, were present in several
sections of the heart, skeletal muscle, trigeminal nerve, kidney,
adrenal gland, tongue, stomach, lung, intestine, trunk, liver, oral
mucosa, lymph node, pituitary, urinary bladder, cerebral medulla,
and cortex. Accompanying edema was most prominent within
intestinal sections and lymphoid tissues. Moderate cellular infiltrates
comprising neutrophils, fewer plasma cells, and other lymphocytes
were noted in the heart, tongue and liver, the latter of which demon-
strated scattered pyknotic cells compatible with hepatocellular
degeneration and necrosis. Characteristic single, variably sized, eosi-
nophilic or amphophilic, smudged, intranuclear inclusion bodies
consistent with herpesviral inclusions were detected within capillary
endothelial cells of the heart, adrenal gland, lung, liver, and oral
mucosa (Fig. 1b). Erythrophagocytosis and mild hemosiderosis
(confirmed by Perl’s Prussian blue stain) were observed in lymph
nodes and liver, respectively.
Preliminary molecular investigation. EEHV DNA was detected in
heart, tongue, trunkmucosa, whole blood, and serum in both rounds
of semi-nested EEHV2/EEHV5/EEHV6 PCR (data not shown).
DNA sequencing revealed that the target region was identical to
that of the index EEHV5 case (EEHV5/#NAP28; GenBank
accession HM060764), as were the sequences obtained using pan-
EEHV and specific EEHV5 primers7. All samples proved negative for
the other EEHV genotypes.
Genome structure and composition. The EEHV5/Vijay genome is
180,800 bp in size, and consists of a unique sequence (U, 175,872 bp)
flanked by a terminal direct repeat (TR, 2464 bp), in the arrangement
TR-U-TR. The genome sizes and structures of EEHV1A/Raman and
EEHV1B/Emelia are similar4. Like the genomes of EEHV1A/Raman
and EEHV1B/Emelia, the EEHV5/Vijay genome contains single,
unpaired C and G residues at the right and left 39-termini,
respectively. Sequence reads representing the junction between the
termini amounted to approximately 10% of the mean number from
the TR-U and U-TR junctions. These may have been generated from
genomes that were circular, concatemeric, or contained additional
copies of TR at the termini.
As calculated for TR-U (i.e. counting TR only once), 33,005
(0.11%) of the 30,004,378 processed reads for EEHV5/Vijaymatched
the genome sequence, and coverage of the EEHV5 sequence was
complete, with an average of 41 reads/nt (range 5–155). In the
assembly of read data against the finished genome, there was no
evidence for significant sequence variation, which indicated that
Vijay had been infected by a single EEHV5 strain. The EEHV5/
Vijay genotype was confirmed from comparisons with data available
in GenBank for three EEHV5 strains, in each case consisting of
several sequences scattered across the left half of the genome. The
aggregate levels of identity for the 14,614 bp (in nine sections) from
the index EEHV5 case (EEHV5/#NAP28) and the 22,143 bp (in 16
sections) from a case annotated as subgenotype EEHV5A (EEHV5A/
#NAP50) are very high, at 99.6 and 99.2%, respectively. The level for
the 24,190 bp (in 13 sections) from a case annotated as subgenotype
EEHV5B (EEHV5B/#NAP58TW) is lower, at 94.1%. These results
indicate that EEHV5/Vijay is an EEHV5A strain.
The locations of open reading frames (ORFs) in EEHV5/Vijay that
encode functional proteins, and fragmented ORFs that used to
encode functional proteins, were predicted by using the criteria
employed for EEHV1A/Raman and EEHV1B/Emelia, and the names
of ORFs were assigned according to the system described and jus-
tified previously for these viruses4. In this system, most EEHV ORFs
that are conserved in the subfamily Betaherpesvirinae are named
after their orthologs in human herpesviruses 6A and 6B26,27, and
are denoted by the prefix U. ORFs that lack orthologs in other genera
in the subfamily are denoted by the prefix EE. The genome of
EEHV5/Vijay contains 120 ORFs (Fig. 2). The seven families of
paralogous ORFs recognized in EEHV1A/Raman and EEHV1B/
Emelia are represented in EEHV5/Vijay: the EE3, deoxyuridine tri-
phosphatase-related protein (DURP), U4, seven transmembrane
domain (7TM), EE20, OX-2, and EE50 families. There are five frag-
mentedORFs: EE44A, EE49A, and EE61 by frameshifts inG:C tracts,
EE62B by a frameshift in a A:T tract, and EE49C by several frame-
shifts of other types. As indicated in Table 1, fragmented ORFs have
been noted previously in EEHV1A/Raman and EEHV1B/Emelia4,
and, from our analysis, are also evident in EEHV1A/Kimba. It should
be noted that ORFs fragmented by frameshifts in G:C or A:T tracts
are also found in members of the genus Cytomegalovirus, and, in
principle, can revert to functionality via selection of length variants28.
For example, in EEHV5/Vijay, the majority of reads containing the
G:C tracts in EE44A and EE61 (13/17 and 11/22, respectively) con-
tains a tract length that results in frameshifting (11 and 9 nt, respect-
ively, as in the consensus sequence). However, aminority of reads (4/
17 and 10/17, respectively) in these ORFs contains a tract length that
does not result in frameshifting (10 and 10 nt, respectively), thus
allowing the cognate protein to be synthesized. This analysis bears
the caveat that tract length variation might result from the PCR-
Figure 1 | Pathology of EEHV5 infection in Vijay. (a) Severe edema and
multifocal subserosal hemorrhages in the dorsal mediastinum. (b)
Hematoxylin and eosin staining of a liver section. The hepatic architecture
is disrupted by hemorrhage and edema, with multifocal fibrin deposits
(arrow) and diffuse mixed cellular infiltrates. The central vessel displays
denuded endothelial cells, congestion, and mild granulocytostasis. Inset:
Herpetic intranuclear inclusion body.
www.nature.com/scientificreports
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based processes used during sequence library preparation, and not
necessarily from genuine variation in the viral genome.
Genome comparisons. Four complete EEHV genomes have now been
sequenced: those of EEHV1A/Raman, EEHV1A/Kimba, EEHV1B/
Emelia, and EEHV5/Vijay. They are largely colinear, and have over-
all percentages of DNA sequence identity as follows: EEHV1A/Raman
to EEHV1A/Kimba, 96.7; EEHV1A/Raman to EEHV1B/Emelia, 92.7;
EEHV1A/Kimba to EEHV1B/Emelia, 92.1; EEHV1A/Raman to
EEHV5/Vijay, 63.1; and EEHV1B/Emelia to EEHV5/Vijay, 63.0.
Figure 2 | Map of the EEHV5/Vijay genome.The copies of TR flankingU are shown in a thicker format. ORFs are shown by coloured arrows, with names
below. Fragmented ORFs are shown in square brackets, and are depicted as intact. Introns are indicated by narrow white bars. Colour shading
indicates core ORFs (present in the ancestor of the subfamilies Alphaherpesvirinae, Betaherpesvirinae, and Gammaherpesvirinae), betagamma ORFs
(present in the subfamilies Betaherpesvirinae andGammaherpesvirinae), betaORFs (present only in the subfamilyBetaherpesvirinae), andORFs belonging
to paralogous families. As well as being members of paralogous families, U54 and U4 are beta ORFs. A putative origin of DNA replication (ori) and a
tandem reiteration (R1) are marked.
www.nature.com/scientificreports
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Table 1 | Features of predicted protein-coding ORFs in EEHV1A, EEHV1B and EEHV5
EEHV ORF
Orthologous
HCMV ORF
ORF
family
Presence of
ORFa Amino acid sequence identity (%)b
Protein namec
R K E V R/K R/E K/E R/V
EE1 98.3 95.2 95.1 58.1 Protein EE1
EE1A 97.9 89.5 90.9 73.9 Protein EE1A
EE2 98.0 99.2 97.7 54.9 Protein EE2
EE3 EE3 A 73.2 26.3 35.9 Protein EE3
EE4 EE3 68.2 36.3 35.9 36.8 Protein EE4
EE5 91.1 47.4 49.0 31.6 Protein EE5
U82 UL115 95.4 69.9 69.5 56.0 Envelope glycoprotein L
U81 UL114 99.7 71.3 71.6 71.8 Uracil-DNA glycosylase
EE6 A 99.0 46.9 Protein EE6
U79 UL112 99.6 85.7 85.9 70.4 Protein UL112
U77 UL105 99.8 99.6 99.4 90.3 Helicase-primase helicase subunit
U76 UL104 100.0 99.3 99.3 87.2 Capsid portal protein
U75 UL103 100.0 98.3 98.3 81.3 Tegument protein UL7
U74 UL102 98.7 98.2 98.5 80.3 Helicase-primase subunit
U73 99.8 98.0 98.0 79.0 DNA replication origin-binding helicase
U72 UL100 99.7 96.7 96.7 89.0 Envelope glycoprotein M
U71 UL99 100.0 90.5 90.5 44.0 Myristylated tegument protein
U70 UL98 99.8 97.9 98.1 72.9 Deoxyribonuclease
U69 UL97 99.6 99.6 99.4 79.8 Tegument serine/threonine protein kinase
U68 UL96 99.2 100.0 99.2 74.6 Tegument protein UL14
U67 UL95 100.0 99.7 99.7 81.7 Protein UL95
U65 UL94 98.5 95.5 94.6 63.9 Tegument protein UL16
U64 UL93 99.8 99.3 99.1 59.3 DNA packaging tegument protein UL17
U63 UL92 100.0 99.5 99.5 92.9 Protein UL92
U62 UL91 100.0 98.9 98.9 75.0 Protein UL91
U60 UL89 100.0 99.4 99.4 95.6 DNA packaging terminase subunit 1
U59 UL88 100.0 99.7 99.7 67.2 Tegument protein UL88
U58 UL87 99.7 99.7 99.7 83.3 Protein UL87
U57 UL86 99.9 98.8 98.9 88.5 Major capsid protein
U56 UL85 100.0 99.3 99.3 91.8 Capsid triplex subunit 2
U54 UL84 DURP 99.6 98.3 98.8 68.8 Protein UL84
U53 UL80 99.2 99.0 99.4 68.1 Capsid maturation protease
U53.5 UL80.5 98.5 98.5 99.2 53.7 Capsid scaffold protein
U52 UL79 100.0 99.6 99.6 81.6 Protein UL79
U51 UL78 97.3 96.6 98.4 71.3 Envelope protein UL78
U50 UL77 99.8 98.3 98.4 74.7 DNA packaging tegument protein UL25
U49 UL76 100.0 99.6 99.6 75.9 Nuclear protein UL24
EE7 99.7 80.6 80.8 65.9 Thymidine kinase
U48 UL75 86.5 65.2 66.9 59.4 Envelope glycoprotein H
U47 UL74 92.5 61.4 60.9 47.5 Envelope glycoprotein O
U46 UL73 92.7 79.2 80.2 56.7 Envelope glycoprotein N
EE8 97.6 64.9 67.3 45.8 Protein EE8
U27 UL44 99.8 99.3 99.0 75.7 DNA polymerase processivity subunit
EE9 100.0 99.7 99.7 84.7 Ribonucleotide reductase subunit 2
U28 UL45 99.9 99.9 99.8 84.5 Ribonucleotide reductase subunit 1
U29 UL46 99.7 99.0 99.3 82.1 Capsid triplex subunit 1
U30 UL47 99.9 97.8 97.8 52.9 Tegument protein UL37
U31 UL48 99.4 96.4 96.2 62.0 Large tegument protein
U32 UL48A 89.9 87.6 90.9 66.3 Small capsid protein
U33 UL49 99.3 99.3 99.4 71.3 Protein UL49
U34 UL50 100.0 100.0 100.0 85.4 Nuclear egress membrane protein
U35 UL51 100.0 100.0 100.0 85.3 DNA packaging protein UL33
U36 UL52 99.6 99.6 100.0 81.2 DNA packaging protein UL32
U37 UL53 100.0 100.0 100.0 92.5 Nuclear egress lamina protein
U38 UL54 99.7 96.0 95.9 81.0 DNA polymerase catalytic subunit
U39 UL55 100.0 86.9 86.9 79.5 Envelope glycoprotein B
U40 UL56 99.9 99.7 99.6 86.3 DNA packaging terminase subunit 2
U41 UL57 99.9 100.0 99.9 81.7 Single-stranded DNA-binding protein
U42 UL69 99.9 99.5 99.6 66.9 Multifunctional expression regulator
U43 UL70 99.3 99.4 99.3 73.3 Helicase-primase primase subunit
U44 UL71 100.0 100.0 100.0 63.0 Tegument protein UL51
EE10 98.7 98.5 99.2 63.1 Protein EE10
EE11 U4 100.0 99.8 99.8 76.7 Protein EE11
U4 UL27 U4 100.0 100.0 100.0 81.0 Protein UL27
www.nature.com/scientificreports
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Table 1 | Continued
EEHV ORF
Orthologous
HCMV ORF
ORF
family
Presence of
ORFa Amino acid sequence identity (%)b
Protein namec
R K E V R/K R/E K/E R/V
U11 UL32 96.2 96.7 98.9 33.1 Tegument protein pp150
U12 UL33 99.7 99.8 99.5 68.4 Envelope glycoprotein UL33
UL34 UL34 100.0 99.4 99.4 73.9 Protein UL34
U14 UL35 91.9 94.0 88.9 49.2 Tegument protein UL35
EE12 92.4 91.1 94.9 34.2 Protein EE12
EE13 98.8 99.5 98.5 61.6 Protein EE13
EE14 97.9 100.0 97.9 44.8 Protein EE14
EE15 91.6 89.3 90.5 49.7 Protein EE15
EE16 65.2 56.9 54.9 38.1 Protein EE16
EE17 96.9 60.7 60.7 39.9 Protein EE17
EE18 7TM F 99.1 98.7 98.7 75.8 Membrane protein EE18
EE19 7TM 99.6 99.6 100.0 69.7 Membrane protein EE19
EE20 EE20 100.0 100.0 100.0 71.1 Membrane protein EE20
EE21 7TM 98.2 98.5 98.9 65.2 Membrane protein EE21
EE22 OX-2 F 85.6 74.4 73.6 26.8 Membrane protein EE22
E22A OX-2 A A A Membrane protein EE22A
EE23 OX-2 78.1 100.0 78.1 30.9 Protein EE23
EE24 93.2 100.0 93.2 41.9 Protein EE24
EE25 98.9 98.9 100.0 58.9 Protein EE25
EE26 7TM 98.3 92.9 92.2 52.8 Membrane protein EE26
EE27 100.0 100.0 100.0 50.0 Protein EE27
EE28 7TM 99.6 99.6 100.0 77.6 Membrane protein EE28
EE29 DURP 100.0 100.0 100.0 71.7 Protein EE29
EE30 96.2 98.1 96.2 27.2 Protein EE30
EE30A 93.3 92.0 98.7 56.0 Protein EE30A
EE31 7TM 98.0 98.0 99.2 51.4 Membrane protein EE31
EE32 EE20 93.9 93.5 97.2 50.8 Protein EE32
EE32A 93.4 100.0 93.4 47.4 Protein EE32A
EE33 7TM 100.0 100.0 100.0 71.5 Membrane protein EE33
EE34 7TM 99.4 99.4 99.4 67.1 Membrane protein EE34
EE35 7TM 99.2 99.2 100.0 57.2 Membrane protein EE35
EE36 7TM 100.0 99.2 99.2 69.1 Membrane protein EE36
EE37 7TM 99.6 100.0 99.6 58.8 Membrane protein EE37
EE38 7TM 100.0 100.0 100.0 64.1 Membrane protein EE38
EE39 7TM 97.8 99.3 98.6 41.1 Membrane protein EE39
EE40 7TM F 96.7 97.1 97.1 47.4 Membrane protein EE40
EE41 7TM 99.6 98.9 99.3 39.0 Membrane protein EE41
EE42 7TM 99.2 99.6 99.6 49.6 Membrane protein EE42
EE43 7TM 99.2 99.6 98.8 65.8 Membrane protein EE43
EE44 F F F A 76.3 70.7 88.2 Protein EE44
EE44A EE50 A A A F Membrane protein EE44A
EE45 7TM 97.0 91.2 93.5 54.7 Membrane protein EE45
EE46 99.5 99.3 98.9 74.7 Beta-1,3-galactosyl-O-glycosyl-glycoprotein
beta-1,6-N-acetylglucosaminyltransferase
EE47 7TM 77.1 95.3 77.1 39.4 Membrane protein EE47
EE48 7TM 97.9 99.3 97.9 35.9 Membrane protein EE48
EE49 7TM 94.2 94.6 93.2 39.7 Membrane protein EE49
EE49A EE50 A A A F Membrane protein EE49A
EE49B EE50 A A A Membrane protein EE49B
EE49C EE50 A A A F Membrane protein EE49C
EE49D EE50 A A A Membrane protein EE49D
EE50 EE50 58.9 100.0 58.9 33.3 Membrane protein EE50
EE51 OX-2 93.9 96.6 95.9 70.7 Membrane protein EE51
EE52 EE50 F 85.1 85.1 87.0 40.7 Membrane protein EE52
EE53 EE50 F A A 42.5 Membrane protein EE53
EE54 EE50 A A A Membrane protein EE54
EE55 EE50 A A F A Membrane protein EE55
EE56 EE50 A A A Membrane protein EE56
EE57 EE50 F F F A 100.0 72.6 72.6 Membrane protein EE57
EE58 EE50 F A 100.0 45.5 45.5 Membrane protein EE58
EE59 7TM F F A Membrane protein EE59
EE60 EE50 F F A A 100.0 Membrane protein EE60
EE61 EE50 F F A F 100.0 32.4 Membrane protein EE61
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Further investigation of similarities among the genomes was carried
out via pairwise alignment of imputed amino acid sequences
(Table 1), and via phylogenetic analysis of core genes in members
of the subfamily Betaherpesvirinae (Fig. 3). As noted for EEHV1A/
Raman and EEHV1B/Emelia4, divergence is particularly marked in
the region near the right terminus containing the EE50 family (Fig. 4),
where many EEHV5 ORFs share less than 40% identity with their
EEHV1 counterparts, and duplications, transpositions, and losses may
have occurred that make the assignment of orthologs problematic
(e.g., the apparent insertion of EE49A–EE49D in EEHV5/Vijay).
The EE50 family is remarkable both in its apparently rapid rate of
evolution and in its inclusion of fragmented ORFs (Fig. 2 and Table 1).
Comparisons among ORFs in the four genomes led to the follow-
ing adjustments to the EEHV1A/Raman and EEHV1B/Emelia
GenBank annotations. EE1A was added because it is conserved to
a greater degree than the overlapping region of EE1. Indeed, it is
possible either that EE1 starts downstream from EE1A, or that
EE1A is located in an unidentified intron in EE1, thus eliminating
the overlap of protein-coding regions. EE30A and EE32A were also
added. The location of the first exon of U12 was corrected to that
reported previously3, and a second exon was added to EE20 and
EE32, that in the latter also having been proposed previously3. EE1,
U73, U53, U52, U30, EE16 (EEHV1A/Raman only), EE19, and EE31
were truncated at their 59-ends, and EE57 was extended at its 59-end.
Several other minor improvements were also made to the ORF
descriptions. It is notable that, as well as some ORFs being present
only in EEHV-1 or EEHV-5 (e.g., EE3 and EE22A, respectively),
some ORFs in EEHV-1B/Emilia and EEHV-5/Vijay lack counter-
parts in EEHV-1A (e.g., EE6), probably having been lost during
evolution of the latter.
Discussion
A series of recent publications2–4,8,10,15,29 has demonstrated the wide-
spread geographic distribution, prevalence, and occurrence of
EEHVs and enhanced our understanding of the molecular charac-
teristics of these novel viruses via the complete genome sequencing of
EEHV1A and EEHV1B. To date, EEHV5 has been associated with
non-fatal clinical infection only10. However, our study demonstrates
that EEHV5must be considered with other EEHVs as a cause of fatal
infection.
Vijay was reported to have suffered from ill-health of undeter-
mined cause over a prolonged period prior to death. It is unclear
whether, and to what extent, this may have contributed to the
development of fatal disease. Of interest in this context is the occur-
rence of a mucocutaneous perianal lesion. Mucosal lesions related to
EEHV1 infection have been described in Asian elephants30, and a
distinctive mucosal lesion in the trunk of an Asian elephant in the
same group was attributed to elephant gammaherpesvirus 531.
Unfortunately, further analysis of Vijay’s lesion was not carried out
at the time. As a result, the underlying cause remains speculative, co-
infection with multiple EEHVs and elephant gammaherpesviruses
being a possibility (7), and young age is probably a factor. However,
PCR testing of a range of other tissues from Vijay failed to reveal the
presence of genotypes of EEHV other than EEHV5, and searches of
the read data obtained from heart tissue using a selection of the most
extensive sequences available in GenBank for genotypes of EEHV
other than EEHV5, and also for elephant gammaherpesvirus geno-
types, were uniformly negative. Most elephants with fatal EEHV-
Table 1 | Continued
EEHV ORF
Orthologous
HCMV ORF
ORF
family
Presence of
ORFa Amino acid sequence identity (%)b
Protein namec
R K E V R/K R/E K/E R/V
EE62 7TM F A 100.0 45.9 Membrane protein EE62
EE62A EE50 A A A Membrane protein EE62A
EE62B 7TM A A A Membrane protein EE62B
EE63 99.7 57.8 57.6 50.3 Alpha-(1,3)-fucosyltransferase
aR, EEHV1A/Raman; K, EEHV1B/Kimba; E, EEHV1B/Emelia; V, EEHV5/Vijay. A, ORF absent; F, ORF fragmented; blank, intact ORF present.
bConceptually repaired versions of fragmented ORFs were used. Blanks indicate that calculations could not be made because one or both of the ORFs are absent from the cognate genomes, or, in the case of
EE59 in EEHV1A/Raman and EEHV1A/Kimba, too greatly fragmented to be repaired.
cConserved proteins are named according to the nomenclature employed in NCBI Reference Sequence files (http://www.ncbi.nlm.nih.gov/genomes/GenomesGroup.cgi?taxid510292). The names are
derived from various herpesvirus systems and not solely from that used for any particular herpesvirus.
Figure 3 | Neighbour-joining phylogenetic tree of the concatenated
amino acid sequences of core genes (U38, U39, U40, U41, U57, U60, U77,
and U81) from members or probable members of the subfamily
Betaherpesvirinae, with recognized assignments of viruses to genera
indicated. The tree is rooted at the midpoint, a position that has been
shown previously to be statistically robust for this subfamily28. Confidence
values are displayed as fractions. HCMV, human cytomegalovirus; CCMV,
chimpanzee cytomegalovirus; GMCMV, green monkey cytomegalovirus;
RhCMV, rhesus cytomegalovirus; OMCMV, owl monkey
cytomegalovirus; SMCMV, squirrel monkey cytomegalovirus; GPCMV,
guinea pig cytomegalovirus; MSHV,Miniopterus schreibersii herpesvirus;
TuHV, tupaiid herpesvirus 1; MCMV, murine cytomegalovirus; RCMVE,
rat cytomegalovirus England; RCMV, rat cytomegalovirus; HHV6A,
human herpesvirus 6A; HHV6B, human herpesvirus 6B; HHV7, human
herpesvirus 7; and PCMV, porcine cytomegalovirus. The scale bar shows nt
differences/nt.
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related disease are juveniles and die within 24 hours of the onset of
clinical signs5,9. Novel treatment approaches, such as the drainage of
pericardial fluid, may have prolonged survival in this case. It is reas-
onable to assume that the detection of increased inflammatory infil-
trates, in particular in the heart, liver, and tongue, which were not a
recorded feature in previous fatality cases, are a reflection of pro-
longed survival.
Pathological findings in fatal cases associated with recognized
EEHV genotypes are typically similar and comprise extensive edema,
effusions, and hemorrhages. However, while the cardiovascular sys-
tem appears the primary site in EEHV1 cases, fatal infection with
EEHV3 has been related to renal medullary hemorrhage, retinal
damage, and tropism for larger veins6. Recent cases of EEHV4-assoc-
iated fatality in Asia have demonstrated hemorrhages in most
organs, including the gastrointestinal, respiratory, and cardiovascu-
lar systems8. Widespread hemorrhages and edema were also evident
in Vijay. In addition, this is the first reported detection of viral
inclusion bodies in the adrenal gland and oral mucosa, with addi-
tional inclusions in the heart, lung, and liver. Taken together, these
findings suggest a less selective organ tropism for EEHV3, EEHV4
and EEHV5, which might reflect higher virulence of the strains
involved6,8.
There is ample evidence that EEHVs are longstanding viruses of
Asian elephants2,10,15,29,30, and surveys into the shedding of EEHVs in
captive collections indicate that almost all animals within herds may
carry and intermittently shed these viruses in the absence of overt
signs10. These observations, together with the EEHV5-induced fat-
ality reported here, have implications for herd management, where
monitoring of viral shedding via PCR has become an option through
the availability of sequence data and highly sensitive qPCR tests32.
Thus far, however, routine investigations, in particular those into
captive populations, remain focused on the detection of EEHV1
and tend to neglect other genotypes. Consequently, it is uncertain
whether the sparse reporting of fatalities associated with other geno-
types is a true reflection of an overall lower prevalence of these
viruses, or whether it is due to the appearance of virulent variants.
The enhanced sequence comparisons possible as a result of the
current study confirm that, among EEHVs as a whole, the EEHV1A
strains are the most closely related to each other, with EEHV1B/
Emelia somewhat more distant and EEHV5/Vijay much more dis-
tant. There is no indication that recombination has occurred between
EEHV5 and EEHV1. In contrast, there are regions of the genome in
which EEHV1A/Raman and EEHV1B/Emelia are more closely
related to each other than is either to EEHV1A/Kimba (for example,
in the amino acid sequences of EE23, EE24, EE47, and EE50;
Table 1). This evidence for recombination between the EEHV1 sub-
genotypes is in accord with their description as being partially chi-
meric3. The apparent occurrence of recombination would render
divisions of EEHV genotypes into subgenotypes (e.g., EEHV1A
and EEHV1B, and EEHV5A and EEHV5B) a potentially problematic
exercise, particularly if PCR assays based on different genes form the
basis of these distinctions.
Figure 4 | Matrix sequence comparison plot of the regions near the right termini of the EEHV5/Vijay and EEHV1A/Raman genomes that
encompass the EE50 gene family. The layout of ORFs in each sequence is illustrated, with shading indicating gene families provided in the key.
FragmentedORFs are shown in square brackets, and are depicted as intact. The position of TR is also shown. Detectable sequence similarity is indicated by
diagonal lines.
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Among the subfamilies of the family Herpesviridae, the genus
Proboscivirus clearly has its closest genetic affinities with the subfam-
ily Betaherpesvirinae. Since this genus forms the earliest evolutionary
branch in this subfamily, it is rather divergent from the other genera.
Thus, eight ORFs (U79, U54, U51, U4, U11, U12, UL34, and U14)
have apparent orthologs only in the subfamilyBetaherpesvirinae, and
two ORFs (EE7 and EE9) have orthologs only in the subfamilies
Alphaherpesvirinae and Gammaherpesvirinae (Fig. 1). The phylo-
genetic data (Fig. 3) support the classification of EEHV5 as the
founding member of a new species (Elephantid herpesvirus 5) in
the genus Proboscivirus, as has been mooted on the basis of short
sequences7. In addition, the current subfamily assignment of the
genus Proboscivirus seems to be satisfactory, and we do not think
that there is a strong case for removing it from its current taxonom-
ical position and assigning it to a new subfamily2.
The EEHVs remain an important threat to a charismatic and
endangered species of major prominence, particularly juvenile ani-
mals. However, the conditions under which EEHVs cause fatal
hemorrhagic disease remain unclear. Recent reports demonstrating
a much higher than expected prevalence of EEHVs, including
EEHV1, in healthy wild and captive Asian elephants, and evidence
showing that wild African elephants carry EEHV2, EEHV3, EEHV6,
and EEHV7 in skin and lung nodules, make it likely that EEHVs are
natural viruses of Asian and African elephants2,10,15,29,30. This case
report, including determination of the viral genome sequence
directly from the animal concerned, adds significantly to our know-
ledge of this fascinating group of viruses, and will facilitate further
research into the role of EEHV5 in fatal infections and the develop-
ment of tests for, and vaccines against, EEHVs.
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